Skip to main content
SMS Pharmaceuticals Ltd logo

SMS Pharmaceuticals Ltd — Investor Relations & Filings

Ticker · SMSPHARMA ISIN · INE812G01025 LEI · 335800XXEADQCB7GJ514 BSE.NS Manufacturing
Filings indexed 747 across all filing types
Latest filing 2021-10-01 Regulatory Filings
Country IN India
Listing BSE.NS SMSPHARMA

About SMS Pharmaceuticals Ltd

https://smspharma.com/

SMS Pharmaceuticals Ltd specializes in the development and large-scale manufacturing of Active Pharmaceutical Ingredients (APIs) and advanced intermediates. The organization operates multiple manufacturing units and research centers, maintaining compliance with international regulatory standards including USFDA approvals. Its core product portfolio covers therapeutic areas such as anti-ulcerants, anti-migraine agents, anti-hypertensives, and anti-retrovirals. Beyond its proprietary product line, the company provides Contract Research and Manufacturing Services (CRAMS), offering expertise in process development, chemical synthesis, and analytical validation. The company focuses on delivering high-quality chemical solutions through integrated research and development capabilities, supporting global supply chains with a commitment to technical excellence and operational efficiency.

Recent filings

Filing Released Lang Actions
Shareholders meeting
Regulatory Filings
2021-10-01 English
Shareholders meeting
Regulatory Filings
2021-09-30 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about the closure of the trading window for insiders due to upcoming unaudited financial results for a specific quarter and half-year period. It references SEBI regulations and trading restrictions but does not contain any financial data, results, or detailed report content. The length is only 1356 characters, indicating it is a brief announcement rather than a full report. Therefore, it is best classified as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2021-09-28 English
Updates
Regulatory Filings Classification · 80% confidence The document contains a table listing shareholder information including folio number, shareholder name, certificate numbers, distinctive numbers, and number of shares. There is no indication of a report, announcement, or financial data. The content resembles a shareholding or ownership record but is very brief and lacks context such as changes in major shareholding or voting results. Given the brevity and nature of the data, it does not fit into categories like Annual Report, Earnings Release, or Voting Results. It is most consistent with a Major Shareholding Notification (MRQ) if it indicated threshold crossing, but no such indication is present. It also does not fit other categories. Therefore, the best fit is Regulatory Filings (RNS) as a fallback for miscellaneous filings that do not neatly fit elsewhere.
2021-09-16 English
Shareholders meeting
Regulatory Filings
2021-09-08 English
Book Closure
Regulatory Filings
2021-09-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.